Clinical Trials Logo

Acute Lymphoid Leukemia (ALL) clinical trials

View clinical trials related to Acute Lymphoid Leukemia (ALL).

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04872595 Active, not recruiting - Clinical trials for Acute Myeloid Leukemia (AML)

A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant

Start date: April 30, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to see if conditioning regimens that include personalized rabbit ATG (P-rATG) help the immune system recover sooner and decrease the chances of transplant-related side effects. Participants in this study will be children and adults who have acute leukemia or myelodysplastic syndrome (MDS), and will receive a standard conditioning regimen to prepare the body for an allogeneic hematopoietic cell transplant (allo-HCT). The conditioning regimen will include r-ATG, one of two combinations of chemotherapy, and possibly total body irradiation (TBI).